Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIIT.L Regulatory News (IIT)

  • There is currently no data for IIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

18 Jul 2017 07:00

RNS Number : 2840L
Independent Investment Trust PLC
18 July 2017
 

The Independent Investment Trust PLC

Legal Entity Identifier: EMMWZ68BJXG580FSQ522

 

Interim Financial Report for the six months ended 31 May 2017

Regulated Information Classification: Half Yearly Financial Report.

 

The following information is disclosed in accordance with DTR 4.2 of the UKLA Listing Rules (half-yearly financial reports).

 

Objective and Policy

The Company's objective is to provide good absolute returns over long periods by investing the great majority of its assets in UK and international quoted securities and, if appropriate, index futures. The portfolio is constructed without reference to the composition of any stockmarket index. Although its investment policy allows gearing, including the use of derivatives, the Company is not permitted to employ gearing whilst it continues to be registered as a small UK Alternative Investment Fund Manager (AIFM). When appropriate, the directors will sanction a relatively concentrated portfolio structure and, depending on its AIFM status, relatively high levels of gearing.

 

Principal Risks and Uncertainties

The principal risks facing the Company, which have not changed since the date of the Company's Annual Report and Financial Statements for the year to 30 November 2016, are financial risk, regulatory risk, custody risk, operational risk, discount/premium volatility risk, political risk and resource risk. An explanation of these risks and how they are being managed or mitigated is set out on pages 9 and 10 of that report, which is available on the Company's website: www.independentinvestmenttrust.co.uk. The Company's policy is designed to allow the Company an unusually high degree of freedom to exploit the directors' judgement. To the extent that the directors' judgement is flawed, future results could be unusually poor.

 

Responsibility Statement

We confirm that to the best of our knowledge:

a) the condensed set of financial statements has been prepared in accordance with FRS 104 'Interim Financial Reporting';

b) the Chairman's Statement includes a fair review of the information required by Disclosure and Transparency Rules 4.2.7R (indication of important events during the first six months, their impact on the financial statements, and a description of principal risks and uncertainties for the remaining six months of the year); and

c) the Interim Financial Report includes a fair review of the information required by Disclosure and Transparency Rules 4.2.8R (disclosure of related party transactions and changes therein).

 

On behalf of the board

Douglas McDougall

Chairman

17 July 2017

 

 

 

Chairman's Statement

 

The six month period ending 31 May 2017 saw our company produce a net asset value total return* of 35.5%. The total returns* notionally attributable to the FTSE All Share Index and the FTSE World Index were 13.6% and 10.1% respectively. Our net asset value per share rose from 397.7p to 536p over the period, and the share price from 353p to 518p, causing the discount to net asset value† to fall from 11.2% to 3.4%. 

Earnings for the half year amounted to 4.43p (4.28p) and we intend to pay an interim dividend of 2p (5p). As always, the outcome for the year will depend upon changes made to the portfolio during the second half of the year, but we expect to recommend a final dividend of 3p with surplus income being distributed by way of special dividend. Over the six months we bought back a total of 60,000 shares for cancellation at a discount† of 7.3%. 

In line with the experience of recent years, it was a relatively uneventful period in economic terms with most parts of the industrialized world enjoying modest growth, low (but rising) inflation and improving employment. Against this background, the widely anticipated decision of the Federal Reserve Bank to start raising interest rates had little impact on stockmarkets, many of which made good progress on the back of favourable corporate earnings trends. A modest recovery in sterling was helpful to our portfolio with its domestic bias.

Once again activity has been dominated by companies that made their initial public offerings (IPOs) during the period, in this case UP Global Sourcing, Medica, Eddie Stobart Logistics and Alfa Financial Software. Together these accounted for £27m of the £38m purchases made during the six months and were showing a profit on cost of £4.9m at 31 May 2017. Most of our sales during the period represented profit taking in long term holdings for which we still have enthusiasm, although we did sell out of Telecom Plus on grounds of valuation. Our net cash balances fell from 4.7% at 30 November 2016 to 2.5% at 31 May 2017.

Our housebuilding holdings have staged a strong recovery from their disappointing performance in the second half of our last financial year. In contrast to the many gloomy predictions a year ago, the market for new homes has remained buoyant, especially where the homes in question have qualified for the government's Help to Buy scheme. Those of our holdings that have low average selling prices and a high exposure to first time buyers have enjoyed excellent trading conditions and produced results well in excess of the expectations we had before the vote to leave the European Union. Those with higher price points have seen a greater hesitancy in their customer base, but have still produced good results. The retirement homes specialist McCarthy and Stone, however, has struggled as its customers all have to sell into a decidedly soggy second hand market in order to finance their purchases. We continue to believe that the long term prospects for the industry are very good, but we recognize that there will be cyclical fluctuations along the way and that these will not always be predictable in advance. It is our confidence in the long term prospects together with our belief that these are not recognized in current valuations that persuade us to continue with our large housebuilding stake. The value of our unchanged stake rose from £51.0m at 30 November 2016 to £67.75m at 31 May 2017.

It has also been an outstanding period for our large technology and telecommunications stake: worth £44.6m at 30 November 2016, it had risen in value to £61.0m by 31 May 2017 after £5.9m of net sales. The star of the show was the robotic process automation company, Blue Prism, which has become something of a stockmarket darling as its software robots have been snapped up by big blue chip companies on both sides of the Atlantic. As always with investments that become fashionable, there is a danger that the share price may have run ahead of itself, but the scale of the opportunity confronting the company argues in favour of maintaining the position. Elsewhere, FDM, Gamma Communications and our old favourite Herald all delivered strong share price performances, of which we took advantage to realize some profits. Kainos enjoyed a modest increase in its share price despite suffering from a hiatus in orders from the NHS. Finally, towards the end of the period we took a stake in Alfa Financial Software at the time of its IPO. Alfa is a leading software provider to the asset finance industry with an impressive client base, a strong proprietary aspect to its products and apparently bright prospects.

A strong share price performance from On the Beach has once again been the feature of our travel and leisure stake, which rose in value from £24.7m at 30 November 2016 to £32.9m at 31 May 2017, after net purchases of less than £0.1m. The strength of the On the Beach share price is the more remarkable for having occurred against a background of difficult trading conditions and continual placings of private equity stock. With the trading outlook now much better and the private equity stake largely sold, we view the immediate future with some optimism, while the long term prospects continue to excite. Solid results from Gym Group have allowed its share price to stage a modest recovery, but that of Hollywood Bowl was largely unmoved by comforting trading news.

Our business services stake has been expanded by both the purchase of Eddie Stobart Logistics and the reclassification of Gama Aviation. Improving results from Gama helped to extend the rally in its share price from very depressed levels, while a surprisingly strong trading performance from Midwich, to which we added during the period, was well received by the market. Eddie Stobart, the firm that has used technology to derive clear competitive advantage in the transport market, had a quiet debut, while the recruitment company SThree, which we reduced during the period, showed some capital appreciation despite experiencing difficult trading conditions. Overall, a stake worth £11.4m at 30 November 2016 had grown in value to £25.9m by 31 May 2017, after net purchases of £9.7m.

The managing director's fascination with UK retailers has not added much value over the life of The Independent, but this has not blunted his enthusiasm for the sector. Indeed, we have taken advantage of a depressed share price resulting from uncharacteristically dull results to add to our old favourite Dunelm, an addition only partially offset by the profits we have taken in last year's IPO, Joules. Our third active holding, Motorpoint, enjoyed a good recovery in its share price on the back of much improved results. Overall, our retail holdings grew in value from £15.2m at 30 November 2016 to £19.3m at 31 May 2017, after net purchases of £1.1m.

Once again, Fever-Tree's performance, both operationally and in share price terms, has been such as to justify a paragraph to itself. Sales growth in all markets, but most particularly in the UK (arguably its most mature market), has been quite extraordinary. The stockmarket was unusually slow to recognize the implications of this at the time of the annual sales announcement, offering us a chance to add to our already large holding on advantageous terms. It can be argued that the shares are now generously valued in relation to market expectations, but such expectations have been hopelessly low in the past. Moreover, we place considerable value on the company's dominant position in the global market for premium soft drink mixers. At the moment, the risk of selling too early, a sin we have already committed on more than one occasion, looks at least as big as the risk of selling too late.

Elsewhere in the portfolio, recent IPOs Medica, Luceco and UP Global Sourcing all produced dazzling returns, while the more mature holdings Ashtead, Polar Capital and Bluefield Solar made more modest progress. NAHL, however, was hurt by continuing uncertainty over the future of its small claims processing business.

In our last annual report, we listed the many features of the economic and political landscape that were of concern to us. This list has not grown any shorter and some of our concerns - for example the political outlook in the UK - have intensified, but this has not prevented world stockmarkets from delivering strong returns. More importantly from our point of view, the current environment is one in which many of our companies are flourishing. It is impossible to predict how long this happy state of affairs will last, but as long term investors we take confidence in the underlying strengths of the businesses we are invested in. 

The principal risks facing the Company are set out at the start of this report. We draw your attention, in particular, to the unusually important role of the directors' judgement in the success or failure of the Company's policy. Related party transactions disclosures are set out in note 7 of the notes to the condensed financial statements below.

 

* Total returns include the reinvestment of dividends on the date the shares are quoted ex-dividend. Source: Baillie Gifford/Thomson Reuters Datastream and relevant underlying index providers. See disclaimer at the end of this announcement.

When the Company's share price is lower than its net asset value per share the shares are said to be trading at a discount. The size of the discount is calculated as the difference between these two figures expressed as a percentage of the net asset value per share. 

 

 

Douglas McDougall

17 July 2017

 

 

List of Investments as at 31 May 2017 (unaudited)

 

Sector

Name

Value

30 Nov

2016

£'000

Net transactions

£'000

Gains/ (losses)

£'000

Value

31 May

2017

£'000

%

Housing

Bellway

4,882

 

 

768 

 

5,650

 

1.9

 

Berkeley Group

4,952

 

 

1,558 

 

6,510

 

2.2

 

Crest Nicholson

13,113

 

 

5,832 

 

18,945

 

6.4

 

McCarthy and Stone

8,315

 

 

1,000 

 

9,315

 

3.1

 

Persimmon

3,398

 

 

1,512 

 

4,910

 

1.7

 

Redrow

16,344

 

 

6,076 

 

22,420

 

7.5

 

 

51,004

 

 

16,746 

 

67,750

 

22.8

Industrials

Ashtead Group

15,640

 

 

20 

 

15,660

 

5.3

Retailing

Dunelm Group

5,908

 

2,388 

 

(796)

 

7,500

 

2.5

 

Joules Group

3,660

 

(1,327)

 

1,912 

 

4,245

 

1.4

 

Land of Leather*

-

 

 

 

-

 

-

 

Motorpoint

5,670

 

 

1,845 

 

7,515

 

2.5

 

 

15,238

 

1,061 

 

2,961 

 

19,260

 

6.4

Consumer Services

AA

5,308

 

(5,194)

 

(114)

 

-

 

-

 

NAHL Group

3,056

 

 

(856)

 

2,200

 

0.7

 

 

8,364

 

(5,194)

 

(970) 

 

2,200

 

0.7

Consumer Goods

Luceco

5,744

 

(1,469)

 

2,968 

 

7,243

 

2.4

 

Up Global Sourcing

-

 

2,730 

 

1,310 

 

4,040

 

1.4

 

 

5,744

 

1,261 

 

4,278 

 

11,283

 

3.8

Travel and Leisure

Hollywood Bowl Group

6,680

 

 

120 

 

6,800

 

2.3

 

On the Beach Group

13,260

 

18 

 

7,093 

 

20,371

 

6.8

 

The Gym Group

4,770

 

 

930 

 

5,700

 

1.9

 

 

24,710

 

18 

 

8,143 

 

32,871

 

11.0

Business Services

Eddie Stobart Logistics

-

 

9,156 

 

(168)

 

8,988

 

3.0

 

Gama Aviation

2,360

 

 

1,920 

 

4,280

 

1.4

 

Midwich

4,945

 

2,069 

 

2,436 

 

9,450

 

3.2

 

SThree

4,125

 

(1,518)

 

538 

 

3,145

 

1.1

 

 

11,430

 

9,707 

 

4,726 

 

25,863

 

8.7

Technology and

Alfa Financial Software

-

 

9,372 

 

678 

 

10,050

 

3.4

Telecommunications

Blue Prism

5,780

 

406 

 

11,636 

 

17,822

 

6.0

 

FDM Group

13,125

 

(7,198)

 

6,110 

 

12,037

 

4.0

 

Gamma Communications

4,735

 

(2,645)

 

770 

 

2,860

 

1.0

 

Herald Investment Trust

16,500

 

(4,638)

 

2,928 

 

14,790

 

5.0

 

Kainos Group

4,455

 

(1,147)

 

176 

 

3,484

 

1.2

 

 

44,595

 

(5,850)

 

22,298 

 

61,043

 

20.6

Beverages

Fever-Tree Drinks

19,242

 

3,789 

 

13,782 

 

36,813

 

12.4

Utilities

Telecom Plus

5,000

 

(4,813)

 

(187)

 

-

 

-

Healthcare

Medica Group

-

 

5,779 

 

3,121 

 

8,900

 

3.0

Non Life Insurance

Polar Capital Global Insurance

Fund - Ireland

4,408

 

-

 

217 

 

4,625

 

1.6

Renewable Energy

Funds

Bluefield Solar Income -

Channel Islands

5,187

 

(2,200)

 

493 

 

3,480

 

1.2

Total Investments

 

210,562

 

3,558 

 

75,628 

 

289,748

 

97.5

Net Liquid Assets

 

10,308

 

(2,722)

 

(15) 

 

7,571

 

2.5

Shareholders' Funds

 

220,870

 

836 

 

75,613 

 

297,319

 

100.0

 

All holdings are in equities domiciled in the UK unless otherwise stated.

* Suspended security.

 

Income statement (unaudited)

 

 

 

 

 

For the six months ended

31 May 2017

 

For the six months ended

31 May 2016

(Audited)

For the year ended

30 November 2016

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on sales of investments

11,310 

11,310 

7,416 

7,416 

13,029 

13,029 

Changes in investment holding gains and losses

64,318 

64,318 

1,924 

1,924 

(7,309)

(7,309)

Currency (losses)/gains

(15)

(15)

(18)

(18)

139 

139 

Income from investments and interest receivable

2,804 

2,804 

2,740 

2,740 

5,091 

5,091 

Other income

13 

13 

14 

14 

48 

48 

Administrative expenses

(356)

(356)

(360)

(360)

(719)

(719)

Net return on ordinary activities before taxation

2,461

75,613 

78,074 

2,394 

9,322 

11,716 

4,420 

5,859 

10,279 

Tax on ordinary activities

Net return on ordinary activities after taxation

2,461 

75,613 

78,074 

2,394 

9,322 

11,716 

4,420 

5,859 

10,279 

Net return per ordinary share (note 3)

4.43p

136.28p

140.71p

4.28p

16.66p

20.94p

7.93p

10.51p

18.44p

Note:

Dividends per share paid and payable in respect of the period (note 4)

2.00p

 

 

5.00p

 

 

7.50p

 

 

 

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in this statement derive from continuing operations.

A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.

 

Balance sheet (unaudited)

 

 

 

 

At 31 May

2017

(Audited))

At 30 November

2016

 

£'000

£'000

Fixed assets

 

 

Investments held at fair value through profit or loss

289,748 

210,562 

Current assets

 

 

Debtors

721 

115 

Cash at bank and in hand

16,400 

10,247 

 

17,121 

10,362 

Creditors

 

 

Amounts falling due within one year

(9,550)

(54)

Net current assets

7,571 

10,308 

Net assets

297,319 

220,870 

 

 

 

Capital and reserves

 

 

Called up share capital

13,867 

13,882 

Share premium account

15,242 

15,242 

Special distributable reserve

16,387 

16,625 

Capital redemption reserve

2,665 

2,650 

Capital reserve

243,595 

167,982 

Revenue reserve

5,563 

4,489 

Shareholders' funds

297,319 

220,870

Net asset value per ordinary share

536.0p

397.7p

Ordinary shares in issue (note 5)

55,470,000 

55,530,000 

 

 

Statement of changes in equity (unaudited)

 

For the six months ended 31 May 2017

 

Called up share capital

£'000

Share premium

account

£'000

Special distributable reserve

£'000

Capital redemption reserve

£'000

Capital

Reserve*

£'000

Revenue reserve

£'000

 

Shareholders'funds

£'000

Shareholders' funds at 1 December 2016

13,882 

15,242

16,625 

2,650

167,982

4,489 

220,870 

Net return on ordinary activities after taxation

-

-

75,613

2,461 

78,074 

Shares bought back for cancellation (note 5)

(15)

-

(238)

15

-

(238)

Dividends paid (note 4)

-

-

-

(1,387)

(1,387)

Shareholders' funds at 31 May 2017

13,867 

15,242

16,387 

2,665

243,595

5,563 

297,319 

 

 

For the six months ended 31 May 2016

 

Called up share capital

£'000

Share premium account

£'000

Special distributable reserve

£'000

Capital redemption reserve

£'000

Capital

Reserve*

£'000

Revenue reserve

£'000

 

Shareholders'funds

£'000

Shareholders' funds at 1 December 2015

14,032 

15,242

18,831

2,500

162,123

6,243 

218,971 

Net return on ordinary activities after taxation

-

-

9,322

2,394 

11,716 

Shares bought back for cancellation (note 5)

(150)

-

(2,206)

150

-

(2,206)

Dividends paid (note 4)

-

-

-

(6,174)

(6,174)

Shareholders' funds at 31 May 2016

13,882 

15,242

16,625 

2,650

171,445

2,463 

222,307 

 

 

* The Capital Reserve balance at 31 May 2017 includes investment holding gains on fixed asset investments of £121,558,000 (31 May 2016 - gains of £66,473,000).

 

Notes to the condensed financial statements (unaudited)

 

1.

The condensed financial statements for the six months to 31 May 2017 comprise the statements set out above and the related notes below. They have been prepared in accordance with FRS 104 'Interim Financial Reporting' and the AIC's Statement of Recommended Practice issued in November 2014 and have not been audited or reviewed by the Auditor pursuant to the Auditing Practices Board Guidance on 'Review of Interim Financial Information'. The financial statements for the six months to 31 May 2017 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 30 November 2016, which included the early adoption of Amendments to FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland - fair value hierarchy disclosures'. The Company has elected not to present a Statement of Cash Flows for the current period as a Statement of Changes in Equity has been provided and substantially all of the Company's investments are highly liquid and are carried at market value. The financial statements for the six months to 31 May 2017 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 30 November 2016.

Fair Value Hierarchy

The fair value hierarchy used to analyse the basis on which the fair values of financial instruments held at fair value through the profit or loss account are measured is described below. The fair value measurements are categorised on the basis of the lowest level input that is significant to the fair value measurement.

Level 1 - using unadjusted quoted prices for identical instruments in an active market;

Level 2 - using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and

Level 3 - using inputs that are unobservable (for which market data is unavailable).

All of the Company's investments at 31 May 2017 and 30 November 2016, which are financial instruments held at fair value through the profit or loss accounts, are categorised as Level 1 in the above hierarchy. For all other financial assets and liabilities carrying value approximates to fair value financial instruments held at fair value through the profit or loss account.

Going Concern

Having considered the Company's current position, self-managed status, the nature of its assets, liabilities, projected income and expenditure together with the Company's investment objective and policy, dividend policy and principal risks and uncertainties, as set out above, it is the directors' opinion that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company's assets, the majority of which are investments in quoted securities which are readily realizable, exceed its liabilities significantly. The Company has no loans. Accordingly, the directors consider it appropriate to adopt the going concern basis of accounting in preparing these financial statements and confirm that they are not aware of any material uncertainties which may affect its ability to continue to do so over a period of at least twelve months from the date of approval of these financial statements.

2.

The financial information contained within this Interim Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 30 November 2016 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's Report on those accounts was not qualified and did not contain statements under sections 498(2), (3) or (4) of the Companies Act 2006.

 

3.

Net return per ordinary share

 

Six months ended 31 May 2017

£'000

 

Six months ended 31 May 2016

£'000

(Audited)

Year ended

30 November 2015

£'000

Revenue return on ordinary activities after taxation

2,461

2,394

4,420

Capital return on ordinary activities after taxation

75,613

9,322

5,859

Total net return

78,074

11,716

10,279

 

The returns per share are based on the above returns and on 55,485,824 (31 May 2016 - 55,946,394; 30 November 2016 - 55,738,196) shares, being the weighted average number of shares in issue during each period.

There was no dilution of returns during any of the financial periods under review.

4.

Dividends

 

Six months ended 31 May 2016

£'000

 

Six months ended 31 May 2015

£'000

(Audited)

Year ended

30 November 2015

£'000

Amounts recognised as distributions in the period:

 

 

 

Previous year's second interim (2016 - 3.00p)

-

1,684

1,684

Previous year's special of 2.50p paid 6 April 2017 (2016 - 3.00p)

1,387

1,684

1,684

Interim (2016 - 5.00p)

-

2,806

2,806

 

1,387

6,174

6,174

Amounts paid and payable in respect of the period:

 

 

 

Interim of 2.00p payable 25 August 2017 (2016 - 5.00p)

1,109

2,806

2,806

 

Special (2016 - 2.50p)

-

-

1,388

 

 

1,109

2,806

4,194

 

The Interim dividend in respect of the six months to 31 May 2017 was declared after the period end and has therefore not been included as a liability in the balance sheet. It is payable on 25 August 2017 to shareholders on the register at the close of business on 4 August 2017. The ex-dividend date is 3 August 2017.

5.

During the period the Company bought back 60,000 ordinary shares of 25p each at a cost of £238,000 for cancellation. At 31 May 2017, the Company had authority to buy back a further 8,314,953 ordinary shares as well as the authority to allot new shares up to an aggregate nominal amount of £4,774,939.

6.

Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sale proceeds, as appropriate. During the period, transaction costs on purchases amounted to £103,000 (31 May 2016 - £6,000; 30 November 2016 - £64,000) and transaction costs on sales amounted to £77,000 (31 May 2016 - £66,000; 30 November 2016 - £99,000).

7.

 Related party transactions

There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have there been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have had such an effect on the Company during that period.

 

Third party data provider disclaimers

 

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom.

No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate.

Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgments, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

FTSE Index data

 

FTSE International Limited ('FTSE') © FTSE 2017. 'FTSE®' is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under licence. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data and no party may rely on any FTSE indices, ratings and/or data underlying data contained in this communication. No further distribution of FTSE Data is permitted without FTSE's express written consent. FTSE does not promote, sponsor or endorse the content of this communication.

 

 

- ends -

 

The Interim Financial Report will be available at www.independentinvestmenttrust.co.uk† and will be posted to shareholders on or around 27 July 2017. None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ZDLFFDDFBBBQ
Date   Source Headline
3rd Nov 202210:45 amRNSNet Asset Value(s)
2nd Nov 202210:41 amRNSNet Asset Value(s)
1st Nov 202212:33 pmRNSNet Asset Value(s)
31st Oct 20222:02 pmRNSResult of Meeting
31st Oct 202210:48 amRNSNet Asset Value(s)
28th Oct 202210:59 amRNSNet Asset Value(s)
27th Oct 202210:35 amRNSNet Asset Value(s)
26th Oct 202210:57 amRNSNet Asset Value(s)
25th Oct 202212:01 pmRNSNet Asset Value(s)
24th Oct 20225:30 pmRNSIndependent Investment Trust PLC
24th Oct 202210:21 amRNSNet Asset Value(s)
21st Oct 202211:17 amRNSNet Asset Value(s)
20th Oct 202211:06 amRNSNet Asset Value(s)
19th Oct 202210:05 amRNSNet Asset Value(s)
18th Oct 202211:17 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
14th Oct 202212:32 pmRNSNet Asset Value(s)
13th Oct 202210:32 amRNSNet Asset Value(s)
12th Oct 202210:18 amRNSNet Asset Value(s)
11th Oct 202210:48 amRNSNet Asset Value(s)
10th Oct 202211:03 amRNSNet Asset Value(s)
7th Oct 202210:12 amRNSNet Asset Value(s)
6th Oct 202211:39 amRNSPre-liquidation interim dividend
6th Oct 202211:33 amRNSPublication of a Circular
6th Oct 202210:15 amRNSNet Asset Value(s)
5th Oct 202210:43 amRNSNet Asset Value(s)
4th Oct 202210:21 amRNSNet Asset Value(s)
3rd Oct 202211:48 amRNSNet Asset Value(s)
30th Sep 202212:33 pmRNSNet Asset Value(s)
29th Sep 202211:00 amRNSNet Asset Value(s)
28th Sep 202212:18 pmRNSNet Asset Value(s)
27th Sep 202210:44 amRNSNet Asset Value(s)
26th Sep 202211:39 amRNSNet Asset Value(s)
23rd Sep 202211:18 amRNSNet Asset Value(s)
22nd Sep 202210:52 amRNSNet Asset Value(s)
21st Sep 202211:53 amRNSNet Asset Value(s)
20th Sep 202212:37 pmRNSNet Asset Value(s)
20th Sep 202210:42 amRNSNet Asset Value(s)
16th Sep 202211:09 amRNSNet Asset Value(s)
15th Sep 202211:19 amRNSNet Asset Value(s)
14th Sep 202210:31 amRNSNet Asset Value(s)
13th Sep 202211:26 amRNSNet Asset Value(s)
12th Sep 202210:47 amRNSNet Asset Value(s)
9th Sep 202211:24 amRNSNet Asset Value(s)
8th Sep 202210:04 amRNSNet Asset Value(s)
7th Sep 202211:10 amRNSNet Asset Value(s)
6th Sep 202211:19 amRNSNet Asset Value(s)
5th Sep 202210:52 amRNSNet Asset Value(s)
2nd Sep 202212:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.